Literature DB >> 26016834

Exercise training improves cardiopulmonary and endothelial function in women with breast cancer: findings from the Diana-5 dietary intervention study.

Francesco Giallauria1, Alessandra Vitelli2, Luigi Maresca2, Maria Santucci De Magistris3, Paolo Chiodini4, Amalia Mattiello3, Marco Gentile3, Maria Mancini2, Alessandra Grieco2, Angelo Russo2, Rosa Lucci2, Giorgio Torella2, Franco Berrino5, Salvatore Panico3, Carlo Vigorito2.   

Abstract

To investigate whether exercise training (ET) improves cardiopulmonary and endothelial function in women with breast cancer (BC). Fifty-one female patients (aged between 39 and 72 years) with a history of primary invasive BC within the previous 5 years and enrolled in the Mediterranean diet-based DIANA (diet and androgens)-5 Trial were subdivided into 2 groups: an ET group (n = 25) followed a formal ET program of moderate intensity (3 session/week on a bicycle at 60-70 % VO2peak for 3 months, followed by one session/week until 1-year follow-up), while a control group (n = 26) did not perform any formal ET. At baseline and at 1-year follow-up, all patients underwent cardiopulmonary exercise stress test (CPET) and measurements of vascular endothelial function by peripheral artery tonometry (Reactive Hyperemia Index, RHI). There were no significant differences between the groups in baseline anthropometrical, BC characteristics, and metabolic profile. No differences in baseline CPET and RHI parameters were found. Peak oxygen consumption (VO2peak) significantly increased in ET group (from 12.4 ± 2.9 to 14.3 ± 3.3 mL/kg/min, p < 0.001) compared to the control group (from 12.8 ± 2.5 to 12.6 ± 2.8 mL/kg/min, p = 0.55; p < 0.001 between groups). Compared to the control group (from 2.0 ± 0.4 to 1.9 ± 0.4, p = 0.62), the ET group showed a significant improvement of RHI after 1 year (from 2.1 ± 0.7 to 2.5 ± 0.8, p < 0.001). Changes in VO2peak were correlated with changes in RHI (ΔVO2peak vs. ΔRHI: r = 0.47, p = 0.017). In BC survivors, ET program improves cardiopulmonary functional capacity and vascular endothelial function after 12 months. Whether these changes may favorably modulate some of the pathophysiological mechanisms implied in cancer evolution should be investigated.

Entities:  

Keywords:  Breast cancer; Cancer; Cardiopulmonary exercise testing; Endothelial function; Exercise training

Mesh:

Year:  2015        PMID: 26016834     DOI: 10.1007/s11739-015-1259-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  45 in total

1.  Obesity and the outcome of young breast cancer patients in the UK: the POSH study.

Authors:  E R Copson; R I Cutress; T Maishman; B K Eccles; S Gerty; L Stanton; D G Altman; L Durcan; C Wong; P D Simmonds; L Jones; D M Eccles
Journal:  Ann Oncol       Date:  2014-10-30       Impact factor: 32.976

Review 2.  Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations.

Authors:  Lee W Jones; Neil D Eves; Mark Haykowsky; Anil A Joy; Pamela S Douglas
Journal:  Lancet Oncol       Date:  2008-08       Impact factor: 41.316

Review 3.  Crossing the endothelial barrier during metastasis.

Authors:  Nicolas Reymond; Bárbara Borda d'Água; Anne J Ridley
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

Review 4.  Exercise, physical activity and breast cancer: the role of tumor-associated macrophages.

Authors:  Jorming Goh; Elizabeth A Kirk; Shu Xian Lee; Warren C Ladiges
Journal:  Exerc Immunol Rev       Date:  2012       Impact factor: 6.308

Review 5.  Exercise interventions on health-related quality of life for people with cancer during active treatment.

Authors:  Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Effect of obesity on prognosis after early-stage breast cancer.

Authors:  Marianne Ewertz; Maj-Britt Jensen; Katrín Á Gunnarsdóttir; Inger Højris; Erik H Jakobsen; Dorte Nielsen; Lars E Stenbygaard; Ulla B Tange; Søren Cold
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

Review 7.  Exercise and cancer rehabilitation: a systematic review.

Authors:  Rosalind R Spence; Kristiann C Heesch; Wendy J Brown
Journal:  Cancer Treat Rev       Date:  2009-12-04       Impact factor: 12.111

8.  Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement.

Authors:  Geerte L Van Sluis; Tatjana M H Niers; Charles T Esmon; Wikky Tigchelaar; Dick J Richel; Harry R Buller; Cornelis J F Van Noorden; C Arnold Spek
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

9.  Two-year multicomprehensive secondary prevention program: favorable effects on cardiovascular functional capacity and coronary risk profile after acute myocardial infarction.

Authors:  Francesco Giallauria; Rosa Lucci; Mariantonietta D'Agostino; Alessandra Vitelli; Luigi Maresca; Maria Mancini; Mario Aurino; Domenico Del Forno; Pantaleo Giannuzzi; Carlo Vigorito
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-10       Impact factor: 2.160

10.  Is obesity an independent prognosis factor in woman breast cancer?

Authors:  Bilal Majed; Thierry Moreau; Kamel Senouci; Rémi J Salmon; Alain Fourquet; Bernard Asselain
Journal:  Breast Cancer Res Treat       Date:  2007-10-16       Impact factor: 4.872

View more
  8 in total

1.  Exercise training improves cardiopulmonary and endothelial function in women with breast cancer: findings from the Diana-5 study.

Authors:  Paolo Giorgini; Davide Grassi; Paolo Di Giosia; Claudio Ferri
Journal:  Intern Emerg Med       Date:  2016-02-26       Impact factor: 3.397

2.  Intensity- and domain-specific physical activity levels between cancer survivors and non-cancer diagnosis individuals: a propensity score matching analysis.

Authors:  Jeongmin Lee; Jihee Min; Dong Hoon Lee; Dong-Woo Kang; Justin Y Jeon
Journal:  Support Care Cancer       Date:  2020-05-19       Impact factor: 3.603

3.  Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors.

Authors:  Kyae Hyung Kim; Seulggie Choi; Kyuwoong Kim; Jooyoung Chang; Sung Min Kim; Seong Rae Kim; Yoosun Cho; Yun Hwan Oh; Gyeongsil Lee; Joung Sik Son; Sang Min Park
Journal:  Breast Cancer Res Treat       Date:  2021-02-18       Impact factor: 4.872

4.  Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis.

Authors:  Jessica M Scott; Emily C Zabor; Emily Schwitzer; Graeme J Koelwyn; Scott C Adams; Tormod S Nilsen; Chaya S Moskowitz; Konstantina Matsoukas; Neil M Iyengar; Chau T Dang; Lee W Jones
Journal:  J Clin Oncol       Date:  2018-06-12       Impact factor: 44.544

5.  Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology.

Authors:  Yu Xie; William J Collins; M William Audeh; Stephen L Shiao; Roberta A Gottlieb; Marc T Goodman; C Noel Bairey Merz; Puja K Mehta
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-12

Review 6.  Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.

Authors:  Dong-Woo Kang; Rebekah L Wilson; Cami N Christopher; Amber J Normann; Oscar Barnes; Jordan D Lesansee; Gyuhwan Choi; Christina M Dieli-Conwright
Journal:  Front Cardiovasc Med       Date:  2022-01-14

7.  Meta-analysis of Exercise Training on Vascular Endothelial Function in Cancer Survivors.

Authors:  Rhys I Beaudry; Yuanyuan Liang; Steven T Boyton; Wesley J Tucker; R Matthew Brothers; Kathryn M Daniel; Roshni Rao; Mark J Haykowsky
Journal:  Integr Cancer Ther       Date:  2018-02-02       Impact factor: 3.279

Review 8.  Oncology and Cardiac Rehabilitation: An Underrated Relationship.

Authors:  E Venturini; G Iannuzzo; A D'Andrea; M Pacileo; L Tarantini; M L Canale; M Gentile; G Vitale; F M Sarullo; R Vastarella; A Di Lorenzo; C Testa; A Parlato; C Vigorito; F Giallauria
Journal:  J Clin Med       Date:  2020-06-10       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.